Literature DB >> 25380065

The tumor suppressor rpl36 restrains KRAS(G12V)-induced pancreatic cancer.

Elayne Provost1, Jennifer M Bailey, Sumar Aldrugh, Shu Liu, Christine Iacobuzio-Donahue, Steven D Leach.   

Abstract

Ribosomal proteins are known to be required for proper assembly of mature ribosomes. Recent studies indicate an additional role for ribosomal proteins as candidate tumor suppressor genes. Pancreatic acinar cells, recently identified as effective cells of origin for pancreatic adenocarcinoma, display especially high-level expression of multiple ribosomal proteins. We, therefore, functionally interrogated the ability of two ribosomal proteins, rpl36 and rpl23a, to alter the response to oncogenic Kras in pancreatic acinar cells using a newly established model of zebrafish pancreatic cancer. These studies reveal that rpl36, but not rpl23a, acts as a haploinsufficient tumor suppressor, as manifested by more rapid tumor progression and decreased survival in rpl36(hi1807/+);ptf1a:gal4VP16(Tg);UAS:GFP-KRAS(G12V) fish compared with their rpl36(+/+);ptf1a:gal4VP16;UAS:GFP-KRAS(G12V) siblings. These results suggest that rpl36 may function as an effective tumor suppressor during pancreatic tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25380065      PMCID: PMC4248247          DOI: 10.1089/zeb.2014.1024

Source DB:  PubMed          Journal:  Zebrafish        ISSN: 1545-8547            Impact factor:   1.985


  28 in total

1.  Screening pancreatic oncogenes in zebrafish using the Gal4/UAS system.

Authors:  Shu Liu; Steven D Leach
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

2.  Nitroreductase-mediated cell ablation in transgenic zebrafish embryos.

Authors:  Harshan Pisharath; Michael J Parsons
Journal:  Methods Mol Biol       Date:  2009

3.  The role of the ribosomal protein S19 C-terminus in altering the chemotaxis of leucocytes by causing functional differences in the C5a receptor response.

Authors:  Hiroshi Nishiura; Rui Zhao; Tetsuro Yamamoto
Journal:  J Biochem       Date:  2011-05-25       Impact factor: 3.387

4.  Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence.

Authors:  Carmen Guerra; Manuel Collado; Carolina Navas; Alberto J Schuhmacher; Isabel Hernández-Porras; Marta Cañamero; Manuel Rodriguez-Justo; Manuel Serrano; Mariano Barbacid
Journal:  Cancer Cell       Date:  2011-06-14       Impact factor: 31.743

5.  Inhibition of the p53-MDM2 interaction by adenovirus delivery of ribosomal protein L23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer.

Authors:  Yafei Zhang; Yongquan Shi; Xiaohua Li; Wenqi Du; Guanhong Luo; Yawen Gou; Xin Wang; Xuegang Guo; Jie Liu; Jie Ding; Kaichun Wu; Daiming Fan
Journal:  J Gene Med       Date:  2010-02       Impact factor: 4.565

6.  Many ribosomal protein mutations are associated with growth impairment and tumor predisposition in zebrafish.

Authors:  Kevin Lai; Adam Amsterdam; Sarah Farrington; Roderick T Bronson; Nancy Hopkins; Jacqueline A Lees
Journal:  Dev Dyn       Date:  2009-01       Impact factor: 3.780

Review 7.  How common are extraribosomal functions of ribosomal proteins?

Authors:  Jonathan R Warner; Kerri B McIntosh
Journal:  Mol Cell       Date:  2009-04-10       Impact factor: 17.970

8.  Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice.

Authors:  Nils Habbe; Guanglu Shi; Robert A Meguid; Volker Fendrich; Farzad Esni; Huiping Chen; Georg Feldmann; Doris A Stoffers; Stephen F Konieczny; Steven D Leach; Anirban Maitra
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-21       Impact factor: 11.205

Review 9.  Molecular pathology of pancreatic cancer: from bench-to-bedside translation.

Authors:  Vincenzo Corbo; Giampaolo Tortora; Aldo Scarpa
Journal:  Curr Drug Targets       Date:  2012-06       Impact factor: 3.465

Review 10.  The other lives of ribosomal proteins.

Authors:  Rital B Bhavsar; Leah N Makley; Panagiotis A Tsonis
Journal:  Hum Genomics       Date:  2010-06       Impact factor: 4.639

View more
  11 in total

1.  Elevated levels of ribosomal proteins eL36 and eL42 control expression of Hsp90 in rhabdomyosarcoma.

Authors:  Sarah Shaikho; Christine C Dobson; Thet Naing; Bahram Samanfar; Houman Moteshareie; Maryam Hajikarimloo; Ashkan Golshani; Martin Holcik
Journal:  Translation (Austin)       Date:  2016-10-04

2.  Selenoprotein H is an essential regulator of redox homeostasis that cooperates with p53 in development and tumorigenesis.

Authors:  Andrew G Cox; Allison Tsomides; Andrew J Kim; Diane Saunders; Katie L Hwang; Kimberley J Evason; Jerry Heidel; Kristin K Brown; Min Yuan; Evan C Lien; Byung Cheon Lee; Sahar Nissim; Bryan Dickinson; Sagar Chhangawala; Christopher J Chang; John M Asara; Yariv Houvras; Vadim N Gladyshev; Wolfram Goessling
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-01       Impact factor: 11.205

3.  Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma.

Authors:  Dany Nassar; Mathilde Latil; Bram Boeckx; Diether Lambrechts; Cédric Blanpain
Journal:  Nat Med       Date:  2015-07-13       Impact factor: 53.440

4.  LncRNA PLAC2 down-regulates RPL36 expression and blocks cell cycle progression in glioma through a mechanism involving STAT1.

Authors:  Yan-Wei Hu; Chun-Min Kang; Jing-Jing Zhao; Ying Nie; Lei Zheng; Hai-Xia Li; Xin Li; Qian Wang; Yu-Rong Qiu
Journal:  J Cell Mol Med       Date:  2017-09-18       Impact factor: 5.310

5.  Inducible Intestine-Specific Expression of krasV12 Triggers Intestinal Tumorigenesis In Transgenic Zebrafish.

Authors:  Jeng-Wei Lu; Divya Raghuram; Pei-Shi Angelina Fong; Zhiyuan Gong
Journal:  Neoplasia       Date:  2018-11-01       Impact factor: 5.715

6.  KRAS G12V Mutation is an Adverse Prognostic Factor of Chinese Gastric Cancer Patients.

Authors:  Xin-Hui Fu; Zhi-Ting Chen; Wen-Hui Wang; Xin-Juan Fan; Yan Huang; Xiao-Bin Wu; Jing-Lin Huang; Jing-Xuan Wang; Han-Jie Lin; Xiao-Li Tan; Lei Wang; Jian-Ping Wang
Journal:  J Cancer       Date:  2019-01-29       Impact factor: 4.207

7.  Development of an Inflammation-Related lncRNA-miRNA-mRNA Network Based on Competing Endogenous RNA in Breast Cancer at Single-Cell Resolution.

Authors:  Jingxing Liu; Shuyuan Xiao; Jing Chen
Journal:  Front Cell Dev Biol       Date:  2022-01-25

8.  Exposure to trace levels of metals and fluoroquinolones increases inflammation and tumorigenesis risk of zebrafish embryos.

Authors:  Dantong Jia; Ruijie Zhang; Jian Shao; Wei Zhang; Leilei Cai; Weiling Sun
Journal:  Environ Sci Ecotechnol       Date:  2022-02-25

9.  Fishing for cures: The alLURE of using zebrafish to develop precision oncology therapies.

Authors:  Matteo Astone; Erin N Dankert; Sk Kayum Alam; Luke H Hoeppner
Journal:  NPJ Precis Oncol       Date:  2017-11-27

Review 10.  Innovative Disease Model: Zebrafish as an In Vivo Platform for Intestinal Disorder and Tumors.

Authors:  Jeng-Wei Lu; Yi-Jung Ho; Shih-Ci Ciou; Zhiyuan Gong
Journal:  Biomedicines       Date:  2017-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.